Hillsdale Investment Management »

Immunovant shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 92k 42.13
2023-09-30 $4.5M 116k 38.39
2023-06-30 $2.6M 138k 18.97
2023-03-31 $4.1M 262k 15.51